Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Are AI pathology tools seeing real biology — or hidden bias? New study raises concerns
Artificial intelligence models designed to predict tumour molecular biomarkers from routine pathology images may rely…
Machine-learning model may help guide adjuvant therapy decisions after oral cavity cancer surgery
Machine-learning models may improve postoperative risk stratification and help guide decisions about adjuvant therapy in…
AI tools may support improved detection of immunotherapy toxicities
Artificial intelligence (AI) approaches may help improve identification and monitoring of immune-related adverse events associated…
S3E8 The Oncology Journal Club: ESMO 2025 Special Part 1
Are you ready for ESMO Bingo? Welcome to Episode 8 of the third series of The Oncology Journal Club! Our Host Craig Underhill is joined by Dr Kate Clarke and Professor Christopher Jackson to unpack ESMO 2025
People with disability are dying from cancers we can actually prevent
Yi Yang, The University of Melbourne; George Disney, The University of Melbourne, and Kirsten Deane, The University of Melbourne People…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.